![Chris Boshoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Boshoff
Präsident bei
SEAGEN INC.
Vermögen: 4 Mio $ am 31.05.2026
Profil
Chris Boshoff currently works at Pfizer Inc., as President-R&D & Chief Scientific Officer from 2025, Seagen, Inc., as President from 2023, and Pfizer (La Jolla), as Vice President-Translational Oncology.
Dr. Boshoff also formerly worked at Advanced Oncotherapy Plc, as Non-Executive Director in 2013 and UCL Cancer Institute Research Trust, as Founding Director.
Dr. Boshoff received his doctorate degree from Institute of Cancer Research Royal Marsden Hospital.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.03.2026 | 162’088 ( 0% ) | 4 Mio $ | 31.05.2026 |
Aktuelle Nachrichten zu Chris Boshoff
Aktive Positionen von Chris Boshoff
| Unternehmen | Position | Beginn |
|---|---|---|
| PFIZER INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2025 |
| SEAGEN INC. | Präsident | 14.12.2023 |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Chris Boshoff
| Unternehmen | Position | Ende |
|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Direktor/Vorstandsmitglied | 25.10.2013 |
UCL Cancer Institute Research Trust | Direktor/Vorstandsmitglied | - |
Ausbildung von Chris Boshoff
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Advanced Oncotherapy Plc
 Advanced Oncotherapy Plc Medical SpecialtiesHealth Technology Develops and provides advanced cancer treatments | Health Technology |
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
UCL Cancer Institute Research Trust | |
Institute of Cancer Research Royal Marsden Hospital
 Institute of Cancer Research Royal Marsden Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
